TD Cowen Issues Pessimistic Forecast for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its price objective lowered by TD Cowen from $450.00 to $440.00 in a report released on Monday, Benzinga reports. The firm currently has a buy rating on the stock.

HCA has been the subject of several other research reports. Truist Financial raised their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Royal Bank of Canada lifted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Leerink Partners lifted their target price on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Finally, Morgan Stanley initiated coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price objective for the company. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $379.11.

HCA Healthcare Trading Up 0.1 %

NYSE HCA opened at $361.08 on Monday. HCA Healthcare has a 12 month low of $223.73 and a 12 month high of $417.14. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The firm has a market capitalization of $94.57 billion, a PE ratio of 18.00, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The business’s 50-day moving average price is $394.11 and its two-hundred day moving average price is $353.54.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Several institutional investors have recently modified their holdings of the business. Bangor Savings Bank increased its position in shares of HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the last quarter. MFA Wealth Advisors LLC purchased a new stake in HCA Healthcare during the second quarter worth about $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC raised its holdings in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare in the second quarter worth $33,000. 62.73% of the stock is owned by institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.